Investing.com - Alexion reported second quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $2.64 on revenue of $1.20B. Analysts polled by Investing.com anticipated EPS of $2.33 on revenue of $1.17B. That compared to EPS of $2.07 on revenue of $1.05B in the same period a year earlier. The company had reported EPS of $2.39 on revenue of $1.14B in the previous quarter.
Alexion follows other major Healthcare sector earnings this month
On July 16, J&J reported second quarter EPS of $2.58 on revenue of $20.56B, compared to forecasts of EPS of $2.46 on revenue of $20.29B.
Novartis ADR earnings beat analysts' expectations on July 18, with second quarter EPS of $1.34 on revenue of $11.76B. Investing.com analysts expected EPS of $1.21 on revenue of $11.49B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar